More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$3.51B
EPS
-0.67
P/E ratio
--
Price to sales
0.54
Dividend yield
--
Beta
1.859676
Previous close
$26.79
Today's open
$26.68
Day's range
$26.68 - $26.89
52 week range
$11.41 - $27.23
show more
CEO
J. Eric Evans
Employees
16000
Headquarters
Brentwood, TN
Exchange
Nasdaq Global Select
Shares outstanding
130881223
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
SGRY Merger Investigation: Surgery Partners Investigated Over $23.50 per Share Take-Private Merger – Contact BFA Law if You Hold Shares
BFA Law is investigating the $23.50 per share merger, announced on October 26, 2026, in which Bon Secours Mercy Health, Inc. is set to acquire Surgery Partners, while Surgery Partners' largest stockholder, Bain Capital, is rolling over its equity into the post-merger entity; current stockholders are notified to contact the firm. NEW YORK, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ: SGRY) is being taken private by Bon Secours Mercy Health, Inc. Surgery Partners is incorporated in Delaware.
GlobeNewsWire • 13 hours ago

Surgery Partners, Inc. Announces Increased Consent Fee in Consent Solicitation Relating to Surgery Center Holdings, Inc.'s 7.250% Senior Notes due 2032
BRENTWOOD, Tenn., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (“Surgery Partners”) (Nasdaq: SGRY) announced today that its indirect wholly owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), has amended its previously announced solicitation of consents (the “Consent Solicitation”) from holders (“Holders”) of its outstanding $1,225,000,000 aggregate principal amount of 7.250% Senior Notes due 2032 (CUSIP Nos. 86881W AF9 / U86786 AD9 / U86786 AE7; ISINs US86881WAF95 / USU86786AD98 / USU86786AE71) (the “Notes”) to certain proposed amendments (the “Proposed Amendments”) to the indenture governing the Notes, dated as of April 10, 2024 (as supplemented, the “Indenture”), among the Issuer, the guarantors party thereto and Wilmington Trust, National Association, as trustee (the “Trustee”), to increase the consent fee payable to Holders who validly deliver (and do not validly revoke) consents prior to the Expiration Time (as defined below) from $2.50 to $5.00 per $1,000 in principal amount of Notes (the “Increased Consent Fee”).
GlobeNewsWire • 13 hours ago

SHAREHOLDER NOTICE: Kaskela Law Firm Investigates Fairness of Proposed $25.00 Per Share Buyout Offer – Fair Price or Inadequately Low for Surgery Partners Inc. (SGRY) Shares?
PHILADELPHIA, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Kaskela Law announces that it is investigating the proposed buyout of Surgery Partners, Inc. (NASDAQ: SGRY) shareholders to determine if the proposed buyout price is inadequately low and unfair to the company's investors. Click here to request additional information about this investigation: https://kaskelalaw.com/case/surgery-partners/ On November 9, 2026, Surgery Partners announced that it had entered into an amended agreement to be acquired by HealthSpan Partners at a price of $25.00 per share in cash.
GlobeNewsWire • Nov 17, 2026

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Stockholders of an Investigation into the Fairness of the Acquisition of Surgery Partners, Inc. (SGRY)
NEW YORK, Nov. 16, 2026 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Surgery Partners, Inc. ("SGRY" or the "Company") (NASDAQ: SGRY) stock prior to October 23, 2026 . You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of SGRY by HealthSpan Partners.
PRNewsWire • Nov 17, 2026

SURGERY PARTNERS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Surgery Partners, Inc.'s Directors for Breach of Fiduciary Duties – SGRY
Scott+Scott Attorneys at Law LLP is investigating whether the directors of Surgery Partners breached their fiduciary duties to the Company's shareholders.
GlobeNewsWire • Nov 16, 2026

Surgery Partners, Inc. Announces Commencement of Consent Solicitation Relating to Surgery Center Holdings, Inc.'s 7.250% Senior Notes due 2032
BRENTWOOD, Tenn., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (“Surgery Partners”) (Nasdaq: SGRY) announced today that its indirect wholly owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), has commenced a solicitation of consents (the “Consent Solicitation”) from holders (“Holders”) of its outstanding $1,225,000,000 aggregate principal amount of 7.250% Senior Notes due 2032 (CUSIP Nos.
GlobeNewsWire • Nov 16, 2026

Top 3 Health Care Stocks That May Collapse This Month
As of Nov. 16, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Benzinga • Nov 16, 2026

SGRY Securities Notice: Surgery Partners Shareholders are Notified to Contact BFA Law about its Investigation into the $23.50 per Share Take-Private Merger
NEW YORK, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ: SGRY) is being taken private by Bon Secours Mercy Health, Inc. Surgery Partners is incorporated in Delaware. If you are a current stockholder of Surgery Partners, Inc., you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/surgery-partners-merger-investigation.
GlobeNewsWire • Nov 11, 2026

SHAREHOLDER BUYOUT ALERT: Kaskela Law LLC Announces Investigation into Proposed Buyout of Surgery Partners, Inc. (SGRY) Shareholders at $23.50 Per Share – Fair Price or Insufficiently Low?
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law announces that it has launched an investigation into the fairness of the proposed buyout of Surgery Partners, Inc. (NASDAQ: SGRY) shareholders to determine whether the proposed buyout price undervalues the company's shares.Click here for additional information: https://kaskelalaw.com/case/surgery-partners/On October 26, 2026, Surgery Partners announced that it had agreed to be acquired by HealthSpan Partners at a price of $23.50 per share in cash. Follo.
Business Wire • Nov 10, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Lumentum Holdings Inc. (Nasdaq – LITE), ARRAY Technologies, Inc. (NASDAQ – ARRY), Surgery Partners, Inc. (Nasdaq – SGRY), Range Resources Corporation (NYSE – RRC)
BALA CYNWYD, Pa., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
GlobeNewsWire • Nov 10, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Surgery Partners Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.